MD Medical Group Announces Personnel Changes
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, today announces changes to its management team.
- Elena Mladova, following the birth of her child, is stepping down from her position as CEO after more than four successful years, with achievements including the Company’s IPO on the London Stock Exchange and rapid expansion across Russia.
- Mark Kurtser assumes the position of CEO.
- Vladimir Mekler, non-executive director of the Group since February 2015, succeeds Mark Kurtser as Chairman of the Board of Directors and the Chairman of the Nomination Committee. Kurtser will remain a member of the Nomination Committee, replacing Mladova.
- Alsu Nazyrova, who is CEO of the Mother and Child Ufa hospital and who has been involved in the company’s regional development, joins the Group’s Board of Directors.
Mark Kurtser, CEO of MD Medical Group, said:
“I want to thank Elena Mladova sincerely for all that she has contributed to us in her position as CEO, during what was a critical stage in MD Medical Group’s development. Elena worked her way from doctor to CEO, assuming the reigns in March 2012. Under her leadership, MDMG emerged as the first healthcare company in the CIS to go public in London, established its position as the leader in women’s health and paediatrics in the region, as well as the largest company in the private healthcare sector overall. Elena oversaw the Group’s active expansion in the regions: during her time as CEO our network more than tripled to 30 hospitals and clinics across the country.
“As I take on the responsibilities of CEO, I intend to work with the rest of the management team to continue to support the Company’s development, and reinforce still further our market leadership in Russia.
“I also want to congratulate Alsu Nazyrova with her appointment to the Group’s Board of Directors. Alsu has worked in our team since 2011 and oversaw the construction and launch of operations in our first regional hospital in Ufa. Her vast experience in our industry and deep understanding of regional development will be an invaluable asset to the Board and will be instrumental as we pursue further our strategy aimed at expanding in the regions of Russia”.
Biographical information:
Alsu Nazyrova, PhD has extensive experience in healthcare and the regional development of medical facilities. She currently serves as the director for Mother and Child Urals region and CEO of Mother and Child Ufa hospital. In 2009, Alsu became the head of the Ufa clinic, which in 2011 entered the Group. Prior to that, she specialised in the promotion of hospital medical products for women’s health at Schering Plough and was a professor in the field of social medicine.
Alsu graduated from Bashkir State Medical University with a specialization in Paediatrics, and later completed her post-graduate studies in Social Hygiene and Healthcare Management. She is a member of the Russian and European Society of Human Reproduction and Embryology.
For further information please contact:
Investors | Media |
Elena Romanova MD Medical Group Investments Plc | EM Sergii Pershyn (+7 968 849 7639) |
MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 30 modern healthcare facilities, including 4 hospitals and 26 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Novokuznetsk, Krasnoyarsk, Omsk, and Barnaul.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.